http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 14 Aug 2026 08:29:28 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Analyst+PT+Change/Eton+Pharmaceuticals+%28ETON%29+PT+Raised+to+%2470+at+B.Riley/26925079.html B.Riley analyst Madison El-Saadi raised the price target on Eton Pharmaceuticals (NASDAQ: ETON) to $70.00 (from $40.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Eton+Pharmaceuticals+%28ETON%29+PT+Raised+to+%2470+at+B.Riley/26925079.html Fri, 14 Aug 2026 08:29:28 -0400 ETON http://www.streetinsider.com/Analyst+PT+Change/Eton+Pharmaceuticals+%28ETON%29+PT+Raised+to+%2470+at+H.C.+Wainwright/26924318.html H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Eton Pharmaceuticals (NASDAQ: ETON) to $70.00 (from $65.00) while maintaining a Buy rating. http://www.streetinsider.com/Analyst+PT+Change/Eton+Pharmaceuticals+%28ETON%29+PT+Raised+to+%2470+at+H.C.+Wainwright/26924318.html Fri, 14 Aug 2026 06:49:27 -0400 ETON http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Special+Reports/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html <p><strong>After-Hours Movers:</strong></p><p><strong>Applied Materials (NASDAQ: AMAT)</strong></p><p>Applied Materials shares dipped 4% in a "sell-the-news" reaction despite delivering a solid fiscal Q3 beat-and-raise. The semiconductor equipment leader posted record Q3 revenue of $9.12 billion and EPS of $3.50, while issuing upbeat Q4 revenue guidance of $9.75–$10.75 billion (well above the $9.54 billion Wall Street consensus). Despite AI-driven materials engineering demand driving record performance, high expectations following a recent sector rally prompted short-term profit-taking.</p><p><strong>DLocal Limited (NASDAQ: DLO)</strong></p><p>DLocal fell 3.5% after narrowly missing second-quarter earnings expectations with an EPS of $0.18 versus the $0.19 consensus. The cross-border payment platform did deliver top-line upside, reporting $399.7 http://www.streetinsider.com/Hot+List/After-Hours+Movers%3A+AMAT%2C+DLO%2C+GLOB%2C+YSS%2C+ETON/26921804.html Thu, 13 Aug 2026 16:30:42 -0400 AMAT DLO ETON GLOB YSS http://www.streetinsider.com/Earnings/Eton+Pharmaceuticals+Inc.+%28ETON%29+Tops+Q2+EPS+by+28c%2C+Raises+Guidance/26921461.html <p>Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q2 EPS of $0.43, $0.28 better than the analyst estimate of $0.15. Revenue for the quarter came in at $37.6 million versus the consensus estimate of $26.88 million.</p><p><strong>GUIDANCE:</strong></p><p>Eton Pharmaceuticals Inc. sees FY2026 revenue of $145 million, versus the consensus of $121 million.</p><p>For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) <a href="http://www.streetinsider.com/ec_earnings.php?q=ETON">click here</a>.</p> http://www.streetinsider.com/Earnings/Eton+Pharmaceuticals+Inc.+%28ETON%29+Tops+Q2+EPS+by+28c%2C+Raises+Guidance/26921461.html Thu, 13 Aug 2026 16:18:52 -0400 ETON http://www.streetinsider.com/Guidance/Eton+Pharmaceuticals+Inc.+%28ETON%29+Tops+Q2+EPS+by+28c%2C+Raises+Guidance/26921461.html <p>Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q2 EPS of $0.43, $0.28 better than the analyst estimate of $0.15. Revenue for the quarter came in at $37.6 million versus the consensus estimate of $26.88 million.</p><p><strong>GUIDANCE:</strong></p><p>Eton Pharmaceuticals Inc. sees FY2026 revenue of $145 million, versus the consensus of $121 million.</p><p>For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) <a href="http://www.streetinsider.com/ec_earnings.php?q=ETON">click here</a>.</p> http://www.streetinsider.com/Guidance/Eton+Pharmaceuticals+Inc.+%28ETON%29+Tops+Q2+EPS+by+28c%2C+Raises+Guidance/26921461.html Thu, 13 Aug 2026 16:18:52 -0400 ETON http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Eton+Pharmaceuticals%2C+++++For%3A+Jun+30/26921448.html si-local-file:///var/storage/secattach/20260813/26921448.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Eton+Pharmaceuticals%2C+++++For%3A+Jun+30/26921448.html Thu, 13 Aug 2026 16:18:00 -0400 ETON O.37299506 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Eton+Pharmaceuticals%2C+++++For%3A+Jun+30/26921448.html si-local-file:///var/storage/secattach/20260813/26921448.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Eton+Pharmaceuticals%2C+++++For%3A+Jun+30/26921448.html Thu, 13 Aug 2026 16:18:00 -0400 ETON O.37299506 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eton+Pharmaceuticals%2C+++++For%3A+Aug+13/26921120.html si-local-file:///var/storage/secattach/20260813/26921120.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eton+Pharmaceuticals%2C+++++For%3A+Aug+13/26921120.html Thu, 13 Aug 2026 16:11:00 -0400 ETON O.37299506 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eton+Pharmaceuticals%2C+++++For%3A+Aug+13/26921120.html si-local-file:///var/storage/secattach/20260813/26921120.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eton+Pharmaceuticals%2C+++++For%3A+Aug+13/26921120.html Thu, 13 Aug 2026 16:11:00 -0400 ETON O.37299506 http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Reports+Second+Quarter+2026+Financial+Results/26920676.html <ul type="disc"><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Record revenue, with Q2 2026 product sales of $37.6 million, representing 99% growth over Q2 2025</li><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Q2 2026 fully diluted GAAP EPS of $0.35, non-GAAP fully diluted EPS of $0.43; EBITDA of $14.1 million, Adjusted EBITDA of $16.2 million</li><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Raising full year revenue guidance, with 2026 revenue now expected to exceed $145 million, up from previous guidance of more than $120 million</li><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Relaunched HEMANGEOL^® May 1^st, patient conversion completed ahead of schedule</li><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Acquired late-stage product candidate ASN-001, expanding the Company’s infantile hemangioma franchise, and providing a potential high-value 2027 NDA submission</li><li style="list-style-position:inside; http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Reports+Second+Quarter+2026+Financial+Results/26920676.html Thu, 13 Aug 2026 16:05:00 -0400 ETON http://www.streetinsider.com/Globe+Newswire/Eton+Pharmaceuticals+Reports+Second+Quarter+2026+Financial+Results/26920676.html <ul type="disc"><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Record revenue, with Q2 2026 product sales of $37.6 million, representing 99% growth over Q2 2025</li><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Q2 2026 fully diluted GAAP EPS of $0.35, non-GAAP fully diluted EPS of $0.43; EBITDA of $14.1 million, Adjusted EBITDA of $16.2 million</li><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Raising full year revenue guidance, with 2026 revenue now expected to exceed $145 million, up from previous guidance of more than $120 million</li><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Relaunched HEMANGEOL^® May 1^st, patient conversion completed ahead of schedule</li><li style="list-style-position:inside; margin-bottom:8pt; text-align:center;">Acquired late-stage product candidate ASN-001, expanding the Company’s infantile hemangioma franchise, and providing a potential high-value 2027 NDA submission</li><li style="list-style-position:inside; http://www.streetinsider.com/Globe+Newswire/Eton+Pharmaceuticals+Reports+Second+Quarter+2026+Financial+Results/26920676.html Thu, 13 Aug 2026 16:05:00 -0400 ETON http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Eton+Pharmaceuticals%2C+++++For%3A+Jul+31++Filed+by%3A+Radosavljevic+Danka/26914043.html si-local-file:///var/storage/secattach/20260812/26914043.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Eton+Pharmaceuticals%2C+++++For%3A+Jul+31++Filed+by%3A+Radosavljevic+Danka/26914043.html Wed, 12 Aug 2026 17:01:00 -0400 ETON O.37299506 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Eton+Pharmaceuticals%2C+++++For%3A+Jul+31++Filed+by%3A+Radosavljevic+Danka/26914043.html si-local-file:///var/storage/secattach/20260812/26914043.html http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Eton+Pharmaceuticals%2C+++++For%3A+Jul+31++Filed+by%3A+Radosavljevic+Danka/26914043.html Wed, 12 Aug 2026 17:01:00 -0400 ETON O.37299506 http://www.streetinsider.com/Analyst+PT+Change/Eton+Pharmaceuticals+%28ETON%29+PT+Raised+to+%2465+at+H.C.+Wainwright/26900951.html (Updated - August 11, 2026 6:52 AM EDT) <p>H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Eton Pharmaceuticals (NASDAQ: ETON) to $65.00 (from $57.00) while maintaining a Buy rating.</p><p>The analyst commented: "Eton is scheduled to report 2Q26 financial results and host a conference call after market close on Thursday, August 13, 2026. Recall that 1Q26 product sales of $24.3M (+73% YoY, +14% QoQ) were above the consensus estimate of $22.3M, led by INCRELEX, ALKINDI SPRINKLE, GALZIN, Carglumic Acid, and the addition of KHINDIVI. On the strength of 1Q26 results, management raised FY26 revenue guidance to >$120M (+$10M above its http://www.streetinsider.com/Analyst+PT+Change/Eton+Pharmaceuticals+%28ETON%29+PT+Raised+to+%2465+at+H.C.+Wainwright/26900951.html Tue, 11 Aug 2026 06:52:26 -0400 ETON http://www.streetinsider.com/Analyst+Comments/Eton+Pharmaceuticals+%28ETON%29+PT+Raised+to+%2465+at+H.C.+Wainwright/26900951.html (Updated - August 11, 2026 6:52 AM EDT) <p>H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Eton Pharmaceuticals (NASDAQ: ETON) to $65.00 (from $57.00) while maintaining a Buy rating.</p><p>The analyst commented: "Eton is scheduled to report 2Q26 financial results and host a conference call after market close on Thursday, August 13, 2026. Recall that 1Q26 product sales of $24.3M (+73% YoY, +14% QoQ) were above the consensus estimate of $22.3M, led by INCRELEX, ALKINDI SPRINKLE, GALZIN, Carglumic Acid, and the addition of KHINDIVI. On the strength of 1Q26 results, management raised FY26 revenue guidance to >$120M (+$10M above its http://www.streetinsider.com/Analyst+Comments/Eton+Pharmaceuticals+%28ETON%29+PT+Raised+to+%2465+at+H.C.+Wainwright/26900951.html Tue, 11 Aug 2026 06:52:26 -0400 ETON http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eton+Pharmaceuticals%2C+++++For%3A+Jul+31/26869998.html si-local-file:///var/storage/secattach/20260805/26869998.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Eton+Pharmaceuticals%2C+++++For%3A+Jul+31/26869998.html Wed, 05 Aug 2026 07:00:00 -0400 ETON O.37299506